The US Court of Appeals for the Washington Federal Circuit upheld the 2009 jury verdict that favored privately-held Spectralytics.
J&J shares are up 0.94%, or $0.62, to $66.71.
Shares of Johnson & Johnson (NYSE:JNJ) are holding gains despite a Bloomberg report that the Cordis unit of the health care products maker lost its appeal of a $22.4 million patent-infringment verdict.
